Photo detail

Stories this photo appears in:

FDA Puts Clinical Hold on Halozyme’s Pancreatic Cancer Treatment Trial

The Food and Drug Administration has halted the study of Halozyme Therapeutics Inc.’s pancreatic cancer treatment trial, just few days after the company voluntary stopped patient enrollment in the drug’s clinical trials.

Tease photo

Halozyme Secures Additional $20M Term Loan

Halozyme Therapeutics Inc. announced it has received an additional $20 million loan from Oxford Finance LLC and Silicon Valley Bank.

Tease photo